SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-219038
Filing Date
2019-08-12
Accepted
2019-08-12 16:27:57
Documents
3
Period of Report
2019-08-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d780162d8k.htm 8-K 17496
2 EX-99.1 d780162dex991.htm EX-99.1 12587
3 GRAPHIC g780162g0812233115007.jpg GRAPHIC 2584
  Complete submission text file 0001193125-19-219038.txt   34902
Mailing Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104
Business Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104 650-391-9740
Eidos Therapeutics, Inc. (Filer) CIK: 0001731831 (see all company filings)

IRS No.: 463733671 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38533 | Film No.: 191016854
SIC: 2834 Pharmaceutical Preparations